Works against mutant strains including Delta
No need for refrigeration during transport and storage
No added stabilisers or chemicals
Safety and immune response clinical trial recruiting now in Melbourne
Efficacy trial planned for USA.
For more information about becoming a volunteer for the COVID-19 EDV™ Vaccine Trial contact:
Despina Anagnostou - St Vincents Hospital Melbourne
+61 3 9231 3490 Despina.Anagnostou@svha.org.au
Learn more about EnGeneIC Dream Vector (EDV™) Nanocell platform technology
Publication in prestigious scientific journal, Cancer Cell, highlighting the ability of EDV™ Nanocells to mount dual assault on Cancer Cells
EDV™ Technology Stimulates Both Innate and Adaptive Immune Response and Confers Long-Term Survival
Abstract accepted to the Annual Meeting of the American Society of Clinical Oncology 2020
Abstract Demonstrates Promising Early Results from Phase I/IIa study in Patients with Recurrent, Metastatic Pancreatic Cancer.